TELA Bio (TELA) FCF Margin Growth (1y) (2019 - 2026)
TELA Bio (TELA) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -473.00 |
| 10 | TELA Bio | 35.91 Mn | 5.49 Mn | 13.94 Mn | -923.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -923.00 |
| Mar 31, 2026 | -655.00 |
| Dec 31, 2025 | 2,351.00 |
| Sep 30, 2025 | 1,936.00 |
| Jun 30, 2025 | 2,602.00 |
| Mar 31, 2025 | 3,501.00 |
| Dec 31, 2024 | 1,604.00 |
| Sep 30, 2024 | 65.00 |
| Jun 30, 2024 | 1,153.00 |
| Mar 31, 2024 | 1,046.00 |
| Dec 31, 2023 | 2,413.00 |
| Sep 30, 2023 | 2,597.00 |
| Jun 30, 2023 | 3,322.00 |
| Mar 31, 2023 | 3,265.00 |
| Dec 31, 2022 | 2,787.00 |
| Sep 30, 2022 | 1,264.00 |
| Jun 30, 2022 | -3,567.00 |
| Mar 31, 2022 | 1,565.00 |
| Dec 31, 2021 | 781.00 |
| Sep 30, 2021 | -1,720.00 |